Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.89B |
| 2 |
Tesla
TSLA
|
+$788M |
| 3 |
Broadcom
AVGO
|
+$772M |
| 4 |
Amazon
AMZN
|
+$768M |
| 5 |
Workday
WDAY
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.5B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$898M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$565M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$441M |
| 5 |
Palo Alto Networks
PANW
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.36% |
| 2 | Consumer Discretionary | 2.24% |
| 3 | Healthcare | 1.2% |
| 4 | Financials | 1.17% |
| 5 | Communication Services | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4576
Editas Medicine
EDIT
$453M
| $1.68M | ﹤0.01% |
166,237
+97,252
| +141% | +$854K |
|
4577
PUT
Plains All American Pipeline
PAA
$16.3B
| $1.68M | ﹤0.01% |
111,100
+54,200
| +95% | +$828K |
|
4578
Cushman & Wakefield Ltd
CWK
$3.23B
| $1.68M | ﹤0.01% |
+155,801
| New | +$1.3M |
|
4579
Virtus Newfleet ABS/MBS ETF
VABS
$112M
| $1.68M | ﹤0.01% |
71,204
+43,437
| +156% | +$1.02M |
|
4580
Global X Silver Miners ETF NEW
SIL
$4.86B
| $1.68M | ﹤0.01% |
59,272
-152,234
| -72% | -$3.91M |
|
|
BCYC
4581
CALL
Bicycle Therapeutics
BCYC
$288M
| $1.68M | ﹤0.01% |
93,000
+3,900
| +4% | +$64.5K |
|
4582
State Street SPDR S&P Bank ETF
KBE
$1.73B
| $1.68M | ﹤0.01% |
36,534
-9,166
| -20% | -$363K |
|
|
JKS
4583
CALL
JinkoSolar
JKS
$873M
| $1.68M | ﹤0.01% |
45,500
+3,100
| +7% | +$100K |
|
4584
PUT
Intellia Therapeutics
NTLA
$1.68B
| $1.68M | ﹤0.01% |
55,100
+11,700
| +27% | +$336K |
|
4585
CALL
Ryder
R
$9.92B
| $1.68M | ﹤0.01% |
14,600
+800
| +6% | +$84.1K |
|
4586
CALL
Kirby Corp
KEX
$7B
| $1.68M | ﹤0.01% |
21,400
-8,800
| -29% | -$688K |
|
4587
CALL
Regions Financial
RF
$26.9B
| $1.68M | ﹤0.01% |
86,600
-8,800
| -9% | -$146K |
|
4588
Agilysys
AGYS
$3.01B
| $1.68M | ﹤0.01% |
+19,784
| New | +$1.61M |
|
4589
Fulton Financial
FULT
$4.65B
| $1.68M | ﹤0.01% |
101,939
-82,771
| -45% | -$1.16M |
|
4590
Acadia Healthcare
ACHC
$2.9B
| $1.68M | ﹤0.01% |
21,553
-34,887
| -62% | -$2.58M |
|
4591
PUT
Equity Residential
EQR
$24.4B
| $1.68M | ﹤0.01% |
27,400
-5,100
| -16% | -$295K |
|
4592
PUT
CSX Corp
CSX
$92.5B
| $1.67M | ﹤0.01% |
48,300
+34,800
| +258% | +$1.11M |
|
|
LAZR
4593
DELISTED
Luminar Technologies
LAZR
| $1.67M | ﹤0.01% |
33,112
+26,282
| +385% | +$1.31M |
|
4594
PUT
CRH
CRH
$67.4B
| $1.67M | ﹤0.01% |
+24,200
| New | +$1.46M |
|
4595
Vanguard Industrials ETF
VIS
$8.49B
| $1.67M | ﹤0.01% |
7,589
-5,751
| -43% | -$1.16M |
|
4596
Protagonist Therapeutics
PTGX
$9.6B
| $1.67M | ﹤0.01% |
72,931
+34,425
| +89% | +$602K |
|
4597
CALL
Clearfield
CLFD
$400M
| $1.67M | ﹤0.01% |
57,500
-1,000
| -2% | -$26.7K |
|
4598
PUT
Ameriprise Financial
AMP
$49.7B
| $1.67M | ﹤0.01% |
4,400
-2,800
| -39% | -$960K |
|
4599
ACI Worldwide
ACIW
$5.27B
| $1.67M | ﹤0.01% |
54,578
-34,224
| -39% | -$857K |
|
4600
CALL
Novavax
NVAX
$1.31B
| $1.67M | ﹤0.01% |
347,900
-237,500
| -41% | -$1.45M |
|
Similar funds
Jane Street's Q4 2023 Portfolio in Review
As of Q4 2023, Jane Street held 10,187 positions worth $384B, up 24% from $309B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jane Street deployed $33.7B of net new capital in Q4 2023, opening 1,659 new positions and adding to 4,053 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, up from 2.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.5B trimmed.
- Jane Street's largest Q4 2023 buy was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
- Jane Street added most to Microsoft in Q4 2023, an estimated $1.89B increase.
- Jane Street's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.5B.
- Jane Street fully exited JPMorgan USD Emerging Markets Sovereign Bond ETF in Q4 2023, selling an estimated $121M.
- Jane Street's ten largest holdings make up 38% of its $384B portfolio in Q4 2023.
- Jane Street opened 1,659 new positions and closed 1,080 in Q4 2023.
- Jane Street's portfolio value rose 24% quarter-over-quarter to $384B.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.